Allworth Financial’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Allworth Financial’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,000	Closed	-$7K	–	974
2018 Q3	$7K	Hold	2,000	–	–	﹤0.01%	616
2018 Q2	$8K	Hold	2,000	–	–	﹤0.01%	562
2018 Q1	$8K	Hold	2,000	–	–	﹤0.01%	531
2017 Q4	$9K	Hold	2,000	–	–	﹤0.01%	501
2017 Q3	$14K	Hold	2,000	–	–	﹤0.01%	423
2017 Q2	$14K	Hold	2,000	–	–	﹤0.01%	435
2017 Q1	$12K	Hold	2,000	–	–	﹤0.01%	427
2016 Q4	$12K	Hold	2,000	–	–	﹤0.01%	382
2016 Q3	$11K	Hold	2,000	–	–	﹤0.01%	407
2016 Q2	$13K	Hold	2,000	–	–	﹤0.01%	367
2016 Q1	$9K	Buy	+2,000	New	+$7.98K	﹤0.01%	396

Allworth Financial's KERX Position: Q4 2018 in Review

Allworth Financial sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 2,000 shares — an estimated $7K sold.

Allworth Financial first reported a position in KERX in Q1 2016 and held it in 11 quarters. The position peaked at $14K in Q3 2017. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Allworth Financial reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Allworth Financial sold 2,000 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $7K.
Allworth Financial first reported a position in Keryx Biopharmaceuticals Inc in Q1 2016 and held it in 11 quarters.
Allworth Financial's Keryx Biopharmaceuticals Inc position peaked at $14K in Q3 2017.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Allworth Financial's 13F filing for Q4 2018, filed 11 Feb 2019.